HUB Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.8K Hold
500
﹤0.01% 1352
2026
Q1
$30.3K Sell
500
-500
-50% -$29.1K ﹤0.01% 1118
2025
Q4
$53.9K Buy
+1,000
New +$48.1K ﹤0.01% 931
2025
Q3
Sell
-2,200
Closed -$102K 861
2025
Q2
$102K Hold
2,200
﹤0.01% 678
2025
Q1
$134K Hold
2,200
0.01% 573
2024
Q4
$47.5K Buy
2,200
+1,000
+83% +$55.9K ﹤0.01% 563
2024
Q3
$23.3K Buy
1,200
+200
+20% +$9.38K ﹤0.01% 537
2024
Q2
$41.5K Buy
+1,000
New +$44.7K ﹤0.01% 484

Other funds holding BMY

HUB Investment Partners's BMY Position: Q2 2026 in Review

HUB Investment Partners increased its Bristol-Myers Squibb (BMY) stake by 44% in Q2 2026, buying an estimated $692K and bringing the position to 39,485 shares worth $2.28M. The position accounts for 0.04% of the portfolio, ranked #280.

HUB Investment Partners first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.73M in Q2 2022. 1,547 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • HUB Investment Partners held 39,485 shares of Bristol-Myers Squibb worth $2.28M as of Q2 2026.
  • HUB Investment Partners bought 12,052 Bristol-Myers Squibb shares in Q2 2026, an estimated $692K.
  • Bristol-Myers Squibb made up 0.04% of HUB Investment Partners's portfolio in Q2 2026, its #280 holding.
  • HUB Investment Partners first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
  • HUB Investment Partners's Bristol-Myers Squibb position peaked at $2.73M in Q2 2022.
  • 1,547 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.